Prospector Partners LLC Has $7.37 Million Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Prospector Partners LLC reduced its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 59.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 272,475 shares of the medical instruments supplier’s stock after selling 402,495 shares during the period. Prospector Partners LLC owned about 0.14% of DENTSPLY SIRONA worth $7,373,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the company. FMR LLC raised its holdings in shares of DENTSPLY SIRONA by 5.1% in the 3rd quarter. FMR LLC now owns 9,056,774 shares of the medical instruments supplier’s stock valued at $245,076,000 after purchasing an additional 436,031 shares during the period. QVIDTVM Management LLC grew its position in shares of DENTSPLY SIRONA by 75.8% in the third quarter. QVIDTVM Management LLC now owns 458,866 shares of the medical instruments supplier’s stock valued at $12,417,000 after purchasing an additional 197,803 shares during the last quarter. Cerity Partners LLC bought a new position in DENTSPLY SIRONA during the 3rd quarter worth $482,000. Raymond James Trust N.A. increased its position in DENTSPLY SIRONA by 37.7% during the third quarter. Raymond James Trust N.A. now owns 13,299 shares of the medical instruments supplier’s stock worth $360,000 after acquiring an additional 3,641 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its holdings in shares of DENTSPLY SIRONA by 50.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 2,065,773 shares of the medical instruments supplier’s stock worth $55,900,000 after purchasing an additional 692,100 shares during the period. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Stock Up 4.0 %

DENTSPLY SIRONA stock opened at $19.52 on Tuesday. The company has a market capitalization of $3.88 billion, a PE ratio of -9.43, a PEG ratio of 1.84 and a beta of 1.02. The firm’s fifty day moving average is $23.25 and its 200 day moving average is $25.05. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 12-month low of $17.21 and a 12-month high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, beating analysts’ consensus estimates of $0.48 by $0.02. The business had revenue of $951.00 million during the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm’s revenue was up .4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.49 EPS. As a group, sell-side analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on XRAY shares. Barrington Research dropped their price objective on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a report on Friday, November 8th. Leerink Partners downgraded DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, November 7th. StockNews.com downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Tuesday, November 19th. Robert W. Baird dropped their target price on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research report on Friday, November 8th. Finally, Leerink Partnrs lowered shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Seven analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $29.50.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.